Form 8-K - Current report:
SEC Accession No. 0001144204-19-048251
Filing Date
2019-10-15
Accepted
2019-10-15 09:04:15
Documents
17
Period of Report
2019-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm19202621_8k.htm   iXBRL 8-K 26447
2 EXHIBIT 10.1 tm19202621_ex10-1.htm EX-10.1 8396
3 EXHIBIT 99.1 tm19202621_ex99-1.htm EX-99.1 10310
7 GRAPHIC tm19202621_ex10-1img001.jpg GRAPHIC 2898
8 GRAPHIC tm19202621_ex10-1img002.jpg GRAPHIC 2876
9 GRAPHIC tm19202621_ex99-1img001.jpg GRAPHIC 3866
  Complete submission text file 0001144204-19-048251.txt   238425

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gild-20191015.xsd EX-101.SCH 3180
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20191015_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20191015_pre.xml EX-101.PRE 22706
12 EXTRACTED XBRL INSTANCE DOCUMENT tm19202621_8k_htm.xml XML 3492
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 191149408
SIC: 2836 Biological Products, (No Diagnostic Substances)